Novartis India Acquires Pfizer鈥檚 Minipress Trademarks for INR 1,250.00 Crore
Novartis India Ltd 路 Intimation 路 07 Sept 2026, 4:54 pm
Novartis India Acquires Pfizer鈥檚 Minipress Trademarks for INR 1,250.00 Crore Novartis India approved the acquisition of Indian trademarks 'Minipress' and 'Minipres' along with related IP rights from Pfizer Inc. and Pfizer Products Inc. for an aggregate consideration of INR 1,250.00 crore on 7th Sep'26. The asset purchase agreement and trademark assignment deeds were executed with simultaneous closing. As per IQVIA MAT Jul'26 data, Minipress XL recorded INR 228.6 crore in revenue, growing at a 4-year CAGR of 6.3% versus the category's 9.0% CAGR. The drug treats hypertension and benign prostatic hyperplasia.
Original exchange filing (PDF)
More announcements from Novartis India Ltd
- Transcript of the Earnings Call held on Wednesday, November 04, 2026. 路 06 Nov 2026
- Submission of the Letter of Offer in connection with the proposed Rights Issue of the Partly Paid-up Equity Shares of the Company. 路 06 Nov 2026
- Intimation is hereby given that the record date for determining the rights entitlement for the Rights Issue of partly paid-up shares of the Company shall be Wednesday, November 11, 2026. 路 05 Nov 2026
- Outcome of the Board Meeting held today i.e. November 04, 2026 路 05 Nov 2026
- Outcome of the meeting of the Rights Issue Committee held today i.e. November 04, 2026 路 05 Nov 2026
- Intimation of the Audio Recording of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2026, held today i.e. on Wednesday, November 04, 2026. 路 04 Nov 2026
- Intimation of the Integrated Unaudited Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Press Release - Unaudited Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
